Soyoung Lee

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

African American

Chemotherapy Induced

Top Venues

Investigational new drugs

Translational and clinical pharmacology

Drug design, development and therapy

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Juyoung Khwarg, Soyoung Lee, In-Jin Jang, Won-Ho Kang, Hye Jung Lee, Kyu Yeon Kim, Ki-Sun Jeong, Chongho Won, Youn Woong Choi, Dae Chul Ha, RaeHoon Jung, Min-Gu Han, Won Tae Jung, Kyu-Yeol Nam, YeSeul Kim, Kyung-Sang Yu, Jaeseong Oh
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects. Drug design, development and therapy 18 (2024)
Juyoung Khwarg, Soyoung Lee, In-Jin Jang, Won-Ho Kang, Hye Jung Lee, Kyu Yeon Kim, Ki-Sun Jeong, Chongho Won, Youn Woong Choi, Dae Chul Ha, RaeHoon Jung, Min-Gu Han, Won Tae Jung, Kyu-Yeol Nam, YeSeul Kim, Kyung-Sang Yu, Jaeseong Oh
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects. Drug design, development and therapy 18 (2024)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Seolah Lee, Hyun Chul Kim, Yoonhyuk Jang, Han Sang Lee, Seon-Jae Ahn, Soon Tae Lee, Keun Hwa Jung, Kyung-Il Park, Ki-Young Jung, Jaeseong Oh, Seung Hwan Lee, Kyung-Sang Yu, In-Jin Jang, Soyoung Lee, Kon Chu, Sang Kun Lee
Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling. Annals of clinical and translational neurology (2023)
Sejung Hwang, Soyoung Lee, Jangsoo Yoon, Jae-Young Chung
Population Pharmacokinetic-Pharmacodynamic Modeling of Carvedilol to Evaluate the Effect of Cytochrome P450 2D6 Genotype on the Heart Rate Reduction. Journal of Korean medical science 38 (22) (2023)
Soyoung Lee, Kyung Taek Hong, In-Jin Jang, Kyung-Sang Yu, Hyoung Jin Kang, Jaeseong Oh
Semimechanistic pharmacokinetic-pharmacodynamic model of tripegfilgrastim for pediatric patients after chemotherapy. CPT: pharmacometrics & systems pharmacology (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Jihyun Jung, Soyoung Lee, Jaeseong Oh, Seung Hwan Lee, In-Jin Jang, Donghwan Lee, Kyung-Sang Yu
Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects. Translational and clinical pharmacology 29 (1) (2021)
Deok Yong Yoon, Soyoung Lee, Mu Seong Ban, In-Jin Jang, Seung Hwan Lee
Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labels. Translational and clinical pharmacology 28 (4) (2020)
Eunsol Yang, Soyoung Lee, Heechan Lee, Inyoung Hwang, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects. Translational and clinical pharmacology 27 (4) (2019)
Soyoung Lee, Seonghae Yoon, Hyewon Chung, Sang Chun Ji, Seo Hyun Yoon, Kyung-Sang Yu, Joo-Youn Cho, Jae-Yong Chung
Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population. Journal of clinical pharmacology 59 (8) (2019)